,outcome,arm 1,arm 2
0,intervention,ixabepilone-alone arm,combination arm
0,Time to prostate-specific antigen progression,"4.4 months ( 95 % CI , 3.1 to 6.9 months )","5.2 months ( 95 % CI , 4.5 to 6.8 months )"
